Holen Sie sich die Stockscreener-App
49.50
4.34%
2.06
Handel nachbörslich:
49.50
Schlusskurs vom Vortag:
$47.44
Offen:
$47.51
24-Stunden-Volumen:
1.34M
Relative Volume:
2.91
Marktkapitalisierung:
$2.69B
Einnahmen:
$1.24B
Nettoeinkommen (Verlust:
$23.68M
KGV:
117.86
EPS:
0.42
Netto-Cashflow:
$108.67M
1W Leistung:
+3.82%
1M Leistung:
+2.80%
6M Leistung:
+6.22%
1J Leistung:
-13.34%
1-Tages-Spanne:
$47.29
$49.80
1-Wochen-Bereich:
$46.75
$49.80
52-Wochen-Spanne:
$43.15
$64.47
Livanova Plc Stock (LIVN) Company Profile
Firmenname
Livanova Plc
Sektor
Branche
Telefon
4402033250662
Adresse
20 EASTBOURNE TERRACE, LONDON
Vergleichen Sie LIVN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
49.50 | 2.69B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
134.95 | 234.06B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.39 | 154.06B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
387.92 | 148.02B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.17 | 115.71B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
72.76 | 42.91B | 5.72B | 4.17B | 490.10M | 6.97 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-04 | Eingeleitet | Goldman | Buy |
| 2024-09-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | Bestätigt | Needham | Buy |
| 2024-02-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-04-14 | Eingeleitet | Mizuho | Neutral |
| 2022-12-21 | Eingeleitet | Barclays | Equal Weight |
| 2022-04-06 | Eingeleitet | Wolfe Research | Outperform |
| 2022-02-24 | Hochstufung | UBS | Neutral → Buy |
| 2021-12-03 | Eingeleitet | Goldman | Buy |
| 2021-08-20 | Bestätigt | Needham | Buy |
| 2021-07-20 | Hochstufung | Needham | Hold → Buy |
| 2021-03-03 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-05 | Herabstufung | Needham | Buy → Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-06-26 | Bestätigt | Needham | Buy |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-02-28 | Bestätigt | Needham | Buy |
| 2018-11-28 | Eingeleitet | UBS | Neutral |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-08 | Eingeleitet | Stifel | Buy |
| 2018-05-31 | Bestätigt | Needham | Buy |
| 2018-02-28 | Bestätigt | Needham | Buy |
Alle ansehen
Livanova Plc Aktie (LIVN) Neueste Nachrichten
LivaNova To Present At The Barclays Global Healthcare Conference -February 21, 2025 at 09:03 am EST - Marketscreener.com
LivaNova to Present at the Barclays Global Healthcare Conference - Business Wire
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire Inc.
U.S. Cardiac Resynchronization Therapy Market is projected - openPR
LivaNova (NASDAQ:LIVN) Stock Rating Upgraded by StockNews.com - MarketBeat
Allspring Global Investments Holdings LLC Trims Stake in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Vagus Nerve Stimulation Market Booming Trends: Future Growth, - openPR
Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR
LivaNova (NASDAQ:LIVN) Share Price Crosses Below 50 Day Moving AverageTime to Sell? - MarketBeat
Natalia Kozmina Joins LivaNova as Chief Human Resources Officer - MPO-mag
(LIVN) Pivots Trading Plans and Risk Controls - Stock Traders Daily
KBC Group NV Purchases 56,580 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova (NASDAQ:LIVN) Given "Buy" Rating at Needham & Company LLC - MarketBeat
Heart Valves Tester Market Surging Forward at 8.18% CAGR, Reaching 11.4 Billion USD by 2032 | Jotec GmbH, - EIN News
Getinge exits surgical perfusion, creating opportunity for Livanova - MedTech Dive
Cardiovascular Devices Market Detailed in New Research Report By 2032 | Livanova PLC, B. Braun Melsungen AG - openPR
Defibrillators Market registering a CAGR of 6.6% from 2021 - openPR
Stifel maintains LivaNova stock Buy rating, $72 target By Investing.com - Investing.com Australia
Stifel maintains LivaNova stock Buy rating, $72 target - MSN
Medical Implants Market Projected To Garner Significant Growth by 2024 -2031:Biotronik, Inc, Livanova Plc, - EIN News
Livanova PLC to Host Earnings Call - ACCESS Newswire
(LIVN) On The My Stocks Page - Stock Traders Daily
Artificial Heart Valve Market Trends is Electrifying Growth Cycle: Medtronic, LivaNova, CryoLife - openPR
Investor Network: Livanova PLC to Host Earnings Call - ACCESS Newswire
LivaNova (NASDAQ:LIVN) shareholders have endured a 35% loss from investing in the stock three years ago - Simply Wall St
Should You Sell LivaNova PLC (LIVN)? - Insider Monkey
LivaNova (NASDAQ:LIVN) Downgraded by StockNews.com to Buy - Defense World
LivaNova (NASDAQ:LIVN) Stock Rating Lowered by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market is Estimated to Grow at a CAGR - openPR
Brokerages Set LivaNova PLC (NASDAQ:LIVN) PT at $69.17 - MarketBeat
LivaNova to Announce Fourth-Quarter and Full-Year 2024 Results - Business Wire
LivaNova's OSPREY Sleep Apnea Trail on aura6000 Meets Primary Endpoint - MSN
LIVN (LivaNova) EV-to-EBITDA : 53.85 (As of Jan. 20, 2025) - GuruFocus.com
Vagus Nerve Stimulators Market Growth in Future Scope 2025-2032 - openPR
StockNews.com Upgrades LivaNova (NASDAQ:LIVN) to Strong-Buy - MarketBeat
JPMorgan Chase & Co. Lowers Stock Position in LivaNova PLC (NASDAQ:LIVN) - Defense World
42,185 Shares in LivaNova PLC (NASDAQ:LIVN) Purchased by Harbor Capital Advisors Inc. - MarketBeat
Nordea Investment Management AB Acquires 12,470 Shares of LivaNova PLC (NASDAQ:LIVN) - MarketBeat
LivaNova PLC appoints Natalia Kozmina as Chief Human Resources Officer - ETHRWorld Middle East
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer - Business Wire
Electroceuticals Market Top Companies StudyMedtronic Plc - openPR
Principal Financial Group Inc. Has $9.01 Million Position in LivaNova PLC (NASDAQ:LIVN) - MarketBeat
Sanctuary Advisors LLC Acquires Shares of 4,268 LivaNova PLC (NASDAQ:LIVN) - Defense World
LivaNova PLC's (NASDAQ:LIVN) Price Is Right But Growth Is Lacking - Simply Wall St
LivaNova PLC (NASDAQ:LIVN) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
(LIVN) Investment Report - Stock Traders Daily
LivaNova (NASDAQ:LIVN) Lowered to Buy Rating by StockNews.com - MarketBeat
Vagus Nerve Stimulators Market Growth in Future Scope 2024-2031 - openPR
Finanzdaten der Livanova Plc-Aktie (LIVN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.10%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):